Monthly Archives: October 2017

Transplant Tailwinds and Momentum
October 16, 2017

This blog was written by Jason Gardner, CEO and co-founder of Magenta Therapeutics, as part of the From The Trenches feature of LifeSciVC.            There’s a proverb that goes like this, “If you want to go

Leave a comment

Launching Science2Startup: Connecting Academics With Venture
October 6, 2017

We’re excited to announce the launch of Science2Startup, an invitation-only university-focused biotech entrepreneurship event aimed at building connectivity across the academic, tech transfer, and venture communities. This event is in many ways a relaunch of the successful URES (University Research

Leave a comment

Nimbus Therapeutics Reaches Summit For Deal With Celgene
October 3, 2017

Today Nimbus and Celgene announced a significant partnership focused on autoimmune and inflammatory diseases. The alliance includes two pre-clinical autoimmune-focused programs in various stages of drug discovery. The most advanced program is a highly selective inhibitor of Tyk2, an immunokinase

Leave a comment

VC-Backed Biotech Financings: Boom Or Bubble?
October 2, 2017

Private biotech funding numbers are in for the third quarter and on an absolute capital basis they are huge: $3.6B flowed into private biotechs, the largest quarter of VC-funding into biopharma ever in the history of our industry, according to

Leave a comment